5 research outputs found

    Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines

    Get PDF
    Scientific relevance. The content of BordetellaΒ pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertussis vaccines, it is both relevant and necessary to study the relationship between the toxicity of B.Β pertussis bacterial cell components and the main quality parameters of these vaccines, including their potency and specific toxicity, as termed in the WHO recommendations and the European Pharmacopoeia.Aim. This study aimed to analyse the effects of B.Β pertussis LOS and residual active PT on the specific toxicity and potency of adsorbed diphtheria, tetanus, and whole-cell pertussis (DTwP) vaccines.Materials and methods. The authors tested 57 commercial batches of adsorbed DTwP vaccines for compliance with the regulatory standards and product specification files. Vaccine batches that failed specific toxicity tests formed GroupΒ 1, and the other batches were designated as GroupΒ 2. The potency was tested in F1Β CBA/CaΓ—C57BL/6J hybrid mice with experimentally induced meningoencephalitis that were immunised with DTwP and reference vaccines. The authors assessed the specific toxicity of DTwP vaccines by changes in body weight following intraperitoneal administration. The toxic activity was assessed indirectly by changes in body weight in the first 16–24Β h (B.Β pertussis LOS) and on dayΒ 7 (PT) after dosing. The authors used Spearman’s rank correlation coefficient to measure the strength of correlation between the toxic activity of vaccine components and the specific toxicity and potency of the vaccine, which were established using the same vaccine batches.Results. The authors measured the toxic activity of LOS and residual active PT in the vaccine batches studied. The correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of LOS were 0.113 (p&gt;0.05) and 0.049 (p&gt;0.05), respectively. Similarly, the correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of PT accounted for 0.595 (p&lt;0.01) and –0.534 (p&lt;0.01), respectively.Conclusions. The authors studied the toxic activity of B.Β pertussis LOS and residual active PT in whole-cell pertussis vaccines and found an inverse correlation between the potency of the vaccines and the toxic activity of residual active PT. The study demonstrated that the specific toxicity test for whole-cell pertussis vaccines fails to detect and quantify B.Β pertussis LOS in the samples. The authors advise to determine the content of LOS in the B.Β pertussis strains intended for the production of whole-cell pertussis vaccines, which is not yet an accepted practice in the Russian Federation

    ВлияниС коклюшного токсина ΠΈ липоолигосахарида Bordetella pertussis Π½Π° ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΈ Π·Π°Ρ‰ΠΈΡ‚Π½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ коклюшной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹

    Get PDF
    Scientific relevance. The content of BordetellaΒ pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertussis vaccines, it is both relevant and necessary to study the relationship between the toxicity of B.Β pertussis bacterial cell components and the main quality parameters of these vaccines, including their potency and specific toxicity, as termed in the WHO recommendations and the European Pharmacopoeia.Aim. This study aimed to analyse the effects of B.Β pertussis LOS and residual active PT on the specific toxicity and potency of adsorbed diphtheria, tetanus, and whole-cell pertussis (DTwP) vaccines.Materials and methods. The authors tested 57 commercial batches of adsorbed DTwP vaccines for compliance with the regulatory standards and product specification files. Vaccine batches that failed specific toxicity tests formed GroupΒ 1, and the other batches were designated as GroupΒ 2. The potency was tested in F1Β CBA/CaΓ—C57BL/6J hybrid mice with experimentally induced meningoencephalitis that were immunised with DTwP and reference vaccines. The authors assessed the specific toxicity of DTwP vaccines by changes in body weight following intraperitoneal administration. The toxic activity was assessed indirectly by changes in body weight in the first 16–24Β h (B.Β pertussis LOS) and on dayΒ 7 (PT) after dosing. The authors used Spearman’s rank correlation coefficient to measure the strength of correlation between the toxic activity of vaccine components and the specific toxicity and potency of the vaccine, which were established using the same vaccine batches.Results. The authors measured the toxic activity of LOS and residual active PT in the vaccine batches studied. The correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of LOS were 0.113 (p&gt;0.05) and 0.049 (p&gt;0.05), respectively. Similarly, the correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of PT accounted for 0.595 (p&lt;0.01) and –0.534 (p&lt;0.01), respectively.Conclusions. The authors studied the toxic activity of B.Β pertussis LOS and residual active PT in whole-cell pertussis vaccines and found an inverse correlation between the potency of the vaccines and the toxic activity of residual active PT. The study demonstrated that the specific toxicity test for whole-cell pertussis vaccines fails to detect and quantify B.Β pertussis LOS in the samples. The authors advise to determine the content of LOS in the B.Β pertussis strains intended for the production of whole-cell pertussis vaccines, which is not yet an accepted practice in the Russian Federation.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π“Π»Π°Π²Π½Ρ‹ΠΌΠΈ Ρ„Π°ΠΊΡ‚ΠΎΡ€Π°ΠΌΠΈ, ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‰ΠΈΠΌΠΈ Ρ€Π΅Π°ΠΊΡ‚ΠΎΠ³Π΅Π½Π½ΠΎΡΡ‚ΡŒ коклюшной Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, принято ΡΡ‡ΠΈΡ‚Π°Ρ‚ΡŒ содСрТаниС липоолигосахарида BordetellaΒ pertussis ΠΈ остаточноС содСрТаниС Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ коклюшного токсина. Π˜Π·ΡƒΡ‡Π΅Π½ΠΈΠ΅ токсичСского воздСйствия ΠΊΠΎΠΊΠ»ΡŽΡˆΠ½Ρ‹Ρ… ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ B.Β pertussis Π½Π° основныС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ качСства Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ коклюшной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹Β (Π·Π°Ρ‰ΠΈΡ‚Π½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΠΈ ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒΒ β€” Ρ‚Π΅Ρ€ΠΌΠΈΠ½Ρ‹, принятыС Π² рСкомСндациях Π’ΠžΠ— ΠΈ ЕвропСйской Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅Π΅) Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎ ΠΈ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎ для ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ качСства ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°.ЦСль. Π˜Π·ΡƒΡ‡Π΅Π½ΠΈΠ΅ токсичСского влияния липоолигосахарида B. pertussis ΠΈ остаточного количСства Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ коклюшного токсина, ΠΏΡ€ΠΈΡΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… Π² Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ адсорбированной коклюшно-Π΄ΠΈΡ„Ρ‚Π΅Ρ€ΠΈΠΉΠ½ΠΎ-столбнячной Π²Π°ΠΊΡ†ΠΈΠ½Π΅, Π½Π° ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΈ Π·Π°Ρ‰ΠΈΡ‚Π½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ИсслСдовали 57 коммСрчСских сСрий адсорбированной коклюшно-Π΄ΠΈΡ„Ρ‚Π΅Ρ€ΠΈΠΉΠ½ΠΎ-столбнячной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ Π½Π° соотвСтствиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ качСства трСбованиям Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½ΠΎΠΉ Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Π°Ρ†ΠΈΠΈ. К Π³Ρ€ΡƒΠΏΠΏΠ΅Β 1 отнСсли сСрии, Π½Π΅ Π²Ρ‹Π΄Π΅Ρ€ΠΆΠ°Π²ΡˆΠΈΠ΅ испытания ΠΏΠΎ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŽ «БпСцифичСская Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒΒ»; ΠΊ Π³Ρ€ΡƒΠΏΠΏΠ΅Β 2Β β€” ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠ΅ трСбованиям. Π—Π°Ρ‰ΠΈΡ‚Π½ΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ опрСдСляли Π² тСстС ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ мСнингоэнцСфалита Π½Π° ΠΌΡ‹ΡˆΠ°Ρ… Π»ΠΈΠ½ΠΈΠΈ F1Β CBAΓ—C57Bl/6j, ΠΈΠΌΠΌΡƒΠ½ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Ρ… ΠΠšΠ”Π‘- ΠΈ рСфСрСнс-Π²Π°ΠΊΡ†ΠΈΠ½Π°ΠΌΠΈ. Π‘ΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° опрСдСляли Π² тСстС измСнСния массы Ρ‚Π΅Π»Π° ΠΌΡ‹ΡˆΠ΅ΠΉ послС Π²Π½ΡƒΡ‚Ρ€ΠΈΠ±Ρ€ΡŽΡˆΠΈΠ½Π½ΠΎΠ³ΠΎ ввСдСния Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ ΠΠšΠ”Π‘. ВоксичСскоС дСйствиС липоолигосахарида ΠΎΡ†Π΅Π½ΠΈΠ²Π°Π»ΠΈ опосрСдованно — Ρ‡Π΅Ρ€Π΅Π· ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ массы Ρ‚Π΅Π»Π°Β ΠΌΡ‹ΡˆΠ΅ΠΉ Π² ΠΏΠ΅Ρ€Π²Ρ‹Π΅ 16–24Β Ρ‡; коклюшного токсина — Π½Π° 7-С сутки. ΠšΠΎΡ€Ρ€Π΅Π»ΡΡ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ анализ тСсноты связи ΠΌΠ΅ΠΆΠ΄Ρƒ установлСнными показатСлями токсичСского дСйствия исслСдуСмых ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² ΠΈ показатСлями спСцифичСской токсичности ΠΈ Π·Π°Ρ‰ΠΈΡ‚Π½ΠΎΠΉ активности, ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹ΠΌΠΈ Π² этих ΠΆΠ΅ сСриях Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΡ€ΠΈ ΠΏΠΎΠΌΠΎΡ‰ΠΈ коэффициСнта Ρ€Π°Π½Π³ΠΎΠ²ΠΎΠΉ коррСляции Π‘ΠΏΠΈΡ€ΠΌΠ΅Π½Π°.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠžΠΏΠΎΡΡ€Π΅Π΄ΠΎΠ²Π°Π½Π½ΠΎ ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΠ»ΠΈ токсичСскоС дСйствиС липоолигосахарида ΠΈ остаточного количСства Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ коклюшного токсина Π² исслСдуСмых сСриях. ΠšΠΎΡΡ„Ρ„ΠΈΡ†ΠΈΠ΅Π½Ρ‚Ρ‹ коррСляции ΠΌΠ΅ΠΆΠ΄Ρƒ показатСлями спСцифичСской токсичности ΠΈ Π·Π°Ρ‰ΠΈΡ‚Π½ΠΎΠΉ активности Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ ΠΈ показатСлями токсичСского дСйствия липоолигосахарида составили 0,113Β (Ρ€&gt;0,05) ΠΈΒ 0,049Β (Ρ€&gt;0,05) соотвСтствСнно, для коклюшного токсина — 0,595Β (Ρ€&lt;0,01) и –0,534Β (Ρ€&lt;0,01) соотвСтствСнно.Π’Ρ‹Π²ΠΎΠ΄Ρ‹. Выявили ΠΈ ΠΎΡ†Π΅Π½ΠΈΠ»ΠΈ токсичСскоС дСйствиС липоолигосахарида B.Β pertussis ΠΈ остаточного количСства Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ коклюшного токсина Π² Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½Π΅; установили ΠΎΠ±Ρ€Π°Ρ‚Π½ΡƒΡŽ ΠΊΠΎΡ€Ρ€Π΅Π»ΡΡ†ΠΈΠΎΠ½Π½ΡƒΡŽ связь ΠΌΠ΅ΠΆΠ΄Ρƒ Π·Π°Ρ‰ΠΈΡ‚Π½ΠΎΠΉ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ ΠΈ токсичСским дСйствиСм остаточного уровня Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ коклюшного токсина. ВСсты продСмонстрировали, Ρ‡Ρ‚ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ, ΠΎΡ†Π΅Π½ΠΈΠ²Π°ΡŽΡ‰ΠΈΠΉ ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΠΊΡΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ коклюшной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, Π½Π΅ ΠΎΡ‚Ρ€Π°ΠΆΠ°Π΅Ρ‚ присутствиС ΠΈ содСрТаниС липоолигосахарида Π² Π²Π°ΠΊΡ†ΠΈΠ½Π΅. ΠžΠΏΠΈΡ€Π°ΡΡΡŒ Π½Π° Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ исслСдования, ΠΌΠΎΠΆΠ½ΠΎ ΡƒΡ‚Π²Π΅Ρ€ΠΆΠ΄Π°Ρ‚ΡŒ, Ρ‡Ρ‚ΠΎ Π² производствСнных ΠΊΠΎΠΊΠ»ΡŽΡˆΠ½Ρ‹Ρ… ΡˆΡ‚Π°ΠΌΠΌΠ°Ρ…, ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ… для изготовлСния Ρ†Π΅Π»ΡŒΠ½ΠΎΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΉ коклюшной Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹, цСлСсообразно ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡ‚ΡŒ содСрТаниС липоолигосахарида B.pertussis, Ρ‡Ρ‚ΠΎ в Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ Π² настоящСС врСмя нС принято

    The effectiveness of spatially cross-linked polymer in the postoperative epidural fibrosis prevention: an experimental study

    Get PDF
    Introduction. Epidural fibrosis is an urgent problem in modern spinal surgery and orthopedics. The formation of connective tissue in the epidural space after performing surgical interventions on the spinal column inevitably leads to adhesion of the latter to the dura mater and compression of neural structures, followed by the formation of clinical and neurological symptoms. The Β search for literary sources in domestic and foreign scientific databases has demonstrated the presence of several works studying the effectiveness of barrier methods for preventing the development of epidural fibrosis. It should be noted that the results of these studies are ambiguous and largely contradictory.The purpose was to study the effectiveness of using a spatially cross-linked polymer in the postoperative lumbar epidural fibrosis prevention in an experiment.Materials and methods. The study included 26 male Wistar rats (average body weight 338.5Β±9.07 g), which were divided into two groups: Group I (control, n = 12): animals underwent laminectomy at the level of vertebral bodies LVII – SIΒ  without application of spatially crosslinked polymer; Group II (experimental, n = 14): animals underwent laminectomy at the level of vertebral bodies LVII – SIΒ  followed by application of a spatially cross-linked polymer to the dura mater. The morphological and instrumental parameters were studied.Results. Significant differences were noted in the severity of epidural fibrosis (Ο‡2 = 14.846, p = 0.003), the number of newly formed vessels (F = 14.371, p&lt;0.001), the number of fibroblasts (F = 11.158, p&lt;0.001), as well as in the severity of vertebral stenosis channe l according to multislice computed tomography (Ο‡2 = 17.207, p=0.002) between the control and experimental groups of animals.Conclusion. Application of a spatially cross-linked polymer to the dura mater is an effective way to prevent the development of postoperative epidural fibrosis

    Acute myocardial ischemia: changes of free circulating mtDNA level in blood after occlusion of the upper one-third left descending branch of the coronary artery

    Get PDF
    The aim of the present study is to analyze the dynamics of free circulating mtDNA level in blood after occlusion of the upper one-third left descending branch of the coronary artery. We showed that the concentration of free circulating mtDNA of blood tends to decrease 24 hours after ligation; it increased and reached values close to control samples 48 and 72 hours after ligation. These data define the need in further investigation of the dynamics of this parameter during later periods of myocardial infarction modeling that will contribute to objective evaluation of its significance for acute myocardial damage diagnostics and prognosis

    The level of blood plasma mitochondrial DNA upon acute myocardium damage in experiment

    Get PDF
    The aim of the present investigation is to study the level of plasma mtDNA as a potential marker of cardiomyocyte damage in 2 and 4 h after subcutaneous injection of adrenaline and during the formed morphological alterations of the myocardium (3 days). Methods. Real time PCR. Male Wistar rats were used as the experimental animals. Results. It was shown that during the increase in the activity of cytolysis biomarkers, at the first hours after adrenaline injection, no reliable increase is observed in the level of free circulating blood mtDNA. A tendency of 2.5-fold increase in this parameter was established at the third day after adrenaline injection during the development of acute inflammatory process in the myocardium. On the whole, further researches are needed on the dynamics of mtDNA level upon acute damage of the myocardium in experimental and clinical investigations for unbiased estimation of the prospects of using the parameter in laboratory diagnostics
    corecore